Cargando…

Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial

BACKGROUND: Titanium dioxide exists in three different crystal lattices, anatase, rutile, and brookite. Anatase coating releases, under ultraviolet (UV) irradiation, free radicals such as ·OH, O(2)(-), HO(2)(-), and H(2)O(2). This potent oxidizing power characteristically results in the lysis of bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Carinci, Francesco, Grecchi, Emma, Bignozzi, Carlo Alberto, Murmura, Giovanna, Piattelli, Adriano, Scarano, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692162/
https://www.ncbi.nlm.nih.gov/pubmed/23814572
http://dx.doi.org/10.4103/1735-3327.109724
_version_ 1782274584218697728
author Carinci, Francesco
Grecchi, Emma
Bignozzi, Carlo Alberto
Murmura, Giovanna
Piattelli, Adriano
Scarano, Antonio
author_facet Carinci, Francesco
Grecchi, Emma
Bignozzi, Carlo Alberto
Murmura, Giovanna
Piattelli, Adriano
Scarano, Antonio
author_sort Carinci, Francesco
collection PubMed
description BACKGROUND: Titanium dioxide exists in three different crystal lattices, anatase, rutile, and brookite. Anatase coating releases, under ultraviolet (UV) irradiation, free radicals such as ·OH, O(2)(-), HO(2)(-), and H(2)O(2). This potent oxidizing power characteristically results in the lysis of bacteria and other organic substances. The purpose of this study was to evaluate the bone response to implants made of titanium alloy or coated with a new combination of anatase and Bactercline(®) product. MATERIALS AND METHODS: In the period between July 2009 and June 2010, 26 patients (10 females and 16 males; median age 51 ± 11 years, min. 27 years, max. 72 years) were operated and 62 implants were inserted. Lost fixtures and peri-implant bone resorption were considered as predictors of clinical outcomes. Pearson χ(2)-test was used. Prosthesis and implant failures, any complications after loading, and peri-implant marginal bone-level changes were assessed by a masked assessor. All patients were followed up to 1 year after loading. RESULTS: No implant was lost. Average bone resorption around implant was 0.33 mm (both for 25 standard and 37 Bactercline-coated implants), and thus no statistical difference was detected. CONCLUSION: These results shown that no adverse effects on osseo-integration were present.
format Online
Article
Text
id pubmed-3692162
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36921622013-06-28 Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial Carinci, Francesco Grecchi, Emma Bignozzi, Carlo Alberto Murmura, Giovanna Piattelli, Adriano Scarano, Antonio Dent Res J (Isfahan) Original Article BACKGROUND: Titanium dioxide exists in three different crystal lattices, anatase, rutile, and brookite. Anatase coating releases, under ultraviolet (UV) irradiation, free radicals such as ·OH, O(2)(-), HO(2)(-), and H(2)O(2). This potent oxidizing power characteristically results in the lysis of bacteria and other organic substances. The purpose of this study was to evaluate the bone response to implants made of titanium alloy or coated with a new combination of anatase and Bactercline(®) product. MATERIALS AND METHODS: In the period between July 2009 and June 2010, 26 patients (10 females and 16 males; median age 51 ± 11 years, min. 27 years, max. 72 years) were operated and 62 implants were inserted. Lost fixtures and peri-implant bone resorption were considered as predictors of clinical outcomes. Pearson χ(2)-test was used. Prosthesis and implant failures, any complications after loading, and peri-implant marginal bone-level changes were assessed by a masked assessor. All patients were followed up to 1 year after loading. RESULTS: No implant was lost. Average bone resorption around implant was 0.33 mm (both for 25 standard and 37 Bactercline-coated implants), and thus no statistical difference was detected. CONCLUSION: These results shown that no adverse effects on osseo-integration were present. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3692162/ /pubmed/23814572 http://dx.doi.org/10.4103/1735-3327.109724 Text en Copyright: © Dental Research Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Carinci, Francesco
Grecchi, Emma
Bignozzi, Carlo Alberto
Murmura, Giovanna
Piattelli, Adriano
Scarano, Antonio
Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
title Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
title_full Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
title_fullStr Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
title_full_unstemmed Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
title_short Bactercline(®)-coated implants: Clinical results up to 1 year after loading from a controlled clinical trial
title_sort bactercline(®)-coated implants: clinical results up to 1 year after loading from a controlled clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692162/
https://www.ncbi.nlm.nih.gov/pubmed/23814572
http://dx.doi.org/10.4103/1735-3327.109724
work_keys_str_mv AT carincifrancesco bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial
AT grecchiemma bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial
AT bignozzicarloalberto bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial
AT murmuragiovanna bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial
AT piattelliadriano bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial
AT scaranoantonio bacterclinecoatedimplantsclinicalresultsupto1yearafterloadingfromacontrolledclinicaltrial